MARCKSL1
MARCKS-related protein
Also known as: F52, MacMARCKS, MLP, MLP1, MRP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49006
- Gene
- MARCKSL1
- Ensembl
- ENSG00000175130
- Chromosome
- 1
- Canonical length
- 195 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Actin filaments,Cytosol
OverviewNCBI Gene
This gene encodes a member of the myristoylated alanine-rich C-kinase substrate (MARCKS) family. Members of this family play a role in cytoskeletal regulation, protein kinase C signaling and calmodulin signaling. The encoded protein affects the formation of adherens junction. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are located on the long arm of chromosomes 6 and 10. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
195 residues, UniProt reviewed canonical sequence.
>P49006|MARCKSL1
1 MGSQSSKAPR GDVTAEEAAG ASPAKANGQE NGHVKSNGDL SPKGEGESPP VNGTDEAAGA
61 TGDAIEPAPP SQGAEAKGEV PPKETPKKKK KFSFKKPFKL SGLSFKRNRK EGGGDSSASS
121 PTEEEQEQGE IGACSDEGTA QEGKAAATPE SQEPQAKGAE ASAASEEEAG PQATEPSTPS
181 GPESGPTPAS AEQNELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MARCKSL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 1,098 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 1,098 nTPM
- midbrain: 535 nTPM
- hippocampal formation: 391 nTPM
- ovary: 378 nTPM
- amygdala: 365 nTPM
- hypothalamus: 301 nTPM
Single-cell type
- tuft cells: 1,026 nCPM
- granulosa cells: 863 nCPM
- breast secretory cells: 628 nCPM
- ovarian stromal cells: 606 nCPM
- enteric stem cells: 559 nCPM
- peritubular myoid cells: 535 nCPM
Immune cell
- eosinophil: 253 nTPM
- non-classical monocyte: 30 nTPM
- naive B-cell: 28 nTPM
- intermediate monocyte: 23 nTPM
- memory B-cell: 20 nTPM
- neutrophil: 18 nTPM
Brain region
- white matter: 1,075 nTPM
- medulla oblongata: 954 nTPM
- cerebellum: 761 nTPM
- pons: 723 nTPM
- midbrain: 682 nTPM
- basal ganglia: 681 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.19
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- cell population proliferation
- central nervous system development
- positive regulation of cell population proliferation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MARCKSL1 as an antibody target. Whether an autoantibody or antibody against MARCKSL1 could matter depends on whether native MARCKSL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MARCKSL1 is annotated at the cell surface, where native MARCKSL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MARCKSL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...